WHO世界卫生组织：2024年儿科癌症药物优化：会议报告（英文版）

The goal of the Paediatric drug optimization for cancer exercise was to develop a PADO priority list of formulations to be prioritized with a time horizon of 3–5 years, and a PADO ‘watch list’ containing promising candidates for investigation and development for children with a time horizon of 5–10 years. The PADO–cancer exercise enables alignment between funders, procurers, market- coordination entities, researchers, innovators, generics manufacturers, product development partnerships and regul